Skip to main content

Table 3 Comparison of baseline (mean ± SD) and mean (±95% CI) changes for blood related markers

From: Effect of D-ribose supplementation on delayed onset muscle soreness induced by plyometric exercise in college students

Measure Pre Change DRIB Change PLAC Group p-value
Creatine kinase(U·L− 1) 71.52(12.09)    
 P 24   98.88(− 127.87, −71.90)a 153.74(− 181.98, − 123.28)a 0.002c
 P 48   81.21(− 135.65, − 28.77)a 138.17(− 193.11, − 81.02)a 0.079
Lactate Dehydrogenase(U·L− 1) 142.18(50.74)    
 P 24   49.17(−98.68, 5.17) 114.97 (− 172.08, − 63.16)a 0.005c
 P 48   34.01(−73.42, 10.21) 162.59(− 209.09, − 121.38)a < 0.001c
Myoglobin (ng·ml− 1) 46.55(26.85)    
 P 24   50.66(− 113.81, − 55.37)a 86.44(− 54.14, − 15.61)a 0.006c
 P 48   16.45(− 124.11, −62.82)a 29.85(−60.99, − 20.58)a 0.230
Superoxide dismutase(U·ml− 1) 48.37(7.57)    
 P 24   11.91(−17.92, − 4.8)a 11.6(− 40.12, − 15.25)a 0.932
 P 48   28.23(− 19.09, − 5.32)a 16.66(−30.3, − 4.22)a 0.077
Total antioxidant capacity(U·ml− 1) 3.59(2.19)    
 P 24   21.48(−30.16, − 12.06)a 14.97(−23.49, − 10.48)a 0.157
 P 48   17.36(−24.87, − 5.89)a 13.11(− 20.34, − 6.7)a 0.248
Malondialdehyde(U·ml− 1) 4.02(1.39)    
 P 24   1.37(− 3.98, 0.2) 3.75(−1.33, 0.78)a 0.029b
 P 48   −0.25(− 5.36, − 0.98) 2.87(− 3.41, − 1.19)a < 0.001c
  1. DRIB D-ribose group, PLAC Placebo group
  2. a99% CI changes that failed to cross 0 indicates a significant difference vs. Pre
  3. bindicates a significant difference vs. Placebo group (p < 0.05)
  4. cindicates a significant difference vs. Placebo group (p < 0.01)
\